Awardee OrganizationTULANE UNIVERSITY OF LOUISIANA
Description
Abstract Text
DESCRIPTION (provided by applicant):
The process by which herpes simplex virus type 1 (HSV-1) establishes latency in neurons of the peripheral nervous system is poorly defined. Although considerable evidence suggests that CD8 + T cells and IFN-gamma contribute to the establishment of latency, direct evidence to support this hypothesis is lacking. In particular, a limiting factor in elucidating the mechanism(s) by which IFN-gamma could potentially inhibit viral replication is that IFN-gamma alone only marginally inhibits HSV-1 replication in vitro. Consequently, it is difficult to determine how IFN-gamma contributes to the establishment of viral latency. We have identified an unexpected event by which IFN-gamma can function m concert with IFN-beta to potently inhibit HSV-1 replication both in vitro and in vivo. The goal of the studies proposed herein is to elucidate the mechanism(s) by which IFN-beta and IFN-gamma inhibit HSV-1 replication and to identify the cellular factors that are involved in this process.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
053785812
UEI
XNY5ULPU8EN6
Project Start Date
30-May-2003
Project End Date
29-May-2006
Budget Start Date
30-May-2003
Budget End Date
29-May-2004
Project Funding Information for 2003
Total Funding
$25,418
Direct Costs
$25,418
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Allergy and Infectious Diseases
$25,418
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F31AI054318-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F31AI054318-01
Patents
No Patents information available for 1F31AI054318-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F31AI054318-01
Clinical Studies
No Clinical Studies information available for 1F31AI054318-01
News and More
Related News Releases
No news release information available for 1F31AI054318-01
History
No Historical information available for 1F31AI054318-01
Similar Projects
No Similar Projects information available for 1F31AI054318-01